180 related articles for article (PubMed ID: 22573848)
1. Low bone mass in behaviorally HIV-infected young men on antiretroviral therapy: Adolescent Trials Network Study 021B.
Mulligan K; Harris DR; Emmanuel P; Fielding RA; Worrell C; Kapogiannis BG; Monte D; Sleasman J; Wilson CM; Aldrovandi GM;
Clin Infect Dis; 2012 Aug; 55(3):461-8. PubMed ID: 22573848
[TBL] [Abstract][Full Text] [Related]
2. Effect of HIV infection on growth and bone density in peripubertal children in the era of antiretroviral therapy: a cross-sectional study in Zimbabwe.
Rukuni R; Rehman AM; Mukwasi-Kahari C; Madanhire T; Kowo-Nyakoko F; McHugh G; Filteau S; Chipanga J; Simms V; Mujuru H; Ward KA; Ferrand RA; Gregson CL
Lancet Child Adolesc Health; 2021 Aug; 5(8):569-581. PubMed ID: 34139202
[TBL] [Abstract][Full Text] [Related]
3. Total body and spinal bone mineral density across Tanner stage in perinatally HIV-infected and uninfected children and youth in PACTG 1045.
Jacobson DL; Lindsey JC; Gordon CM; Moye J; Hardin DS; Mulligan K; Aldrovandi GM;
AIDS; 2010 Mar; 24(5):687-96. PubMed ID: 20168204
[TBL] [Abstract][Full Text] [Related]
4. Predictors of bone mineral density in human immunodeficiency virus-1 infected children.
Jacobson DL; Spiegelman D; Duggan C; Weinberg GA; Bechard L; Furuta L; Nicchitta J; Gorbach SL; Miller TL
J Pediatr Gastroenterol Nutr; 2005 Sep; 41(3):339-46. PubMed ID: 16131991
[TBL] [Abstract][Full Text] [Related]
5. Bone mineral density in children and adolescents with perinatal HIV infection.
DiMeglio LA; Wang J; Siberry GK; Miller TL; Geffner ME; Hazra R; Borkowsky W; Chen JS; Dooley L; Patel K; van Dyke RB; Fielding RA; Gurmu Y; Jacobson DL;
AIDS; 2013 Jan; 27(2):211-20. PubMed ID: 23032412
[TBL] [Abstract][Full Text] [Related]
6. Older age at initiation of antiretroviral therapy predicts low bone mineral density in children with perinatally-infected HIV in Zimbabwe.
Gregson CL; Hartley A; Majonga E; McHugh G; Crabtree N; Rukuni R; Bandason T; Mukwasi-Kahari C; Ward KA; Mujuru H; Ferrand RA
Bone; 2019 Aug; 125():96-102. PubMed ID: 31082498
[TBL] [Abstract][Full Text] [Related]
7. Effect of different antiretroviral drug regimens on body fat distribution of HIV-infected South African women.
Goedecke JH; Micklesfield LK; Levitt NS; Lambert EV; West S; Maartens G; Dave JA
AIDS Res Hum Retroviruses; 2013 Mar; 29(3):557-63. PubMed ID: 23330599
[TBL] [Abstract][Full Text] [Related]
8. Body composition in HIV-infected patients receiving highly active antiretroviral therapy.
Chițu-Tișu CE; Barbu EC; Lazăr M; Bojincă M; Tudor AM; Hristea A; Abagiu AO; Ion DA; Bădărău AI
Acta Clin Belg; 2017 Feb; 72(1):55-62. PubMed ID: 27724840
[TBL] [Abstract][Full Text] [Related]
9. Impact of antiretroviral therapy on bone metabolism markers in HIV-seropositive patients.
Marques de Menezes EG; de Paula FJ; Machado AA; de Assis Pereira F; Barbosa Júnior F; Navarro AM
Bone; 2013 Nov; 57(1):62-7. PubMed ID: 23891908
[TBL] [Abstract][Full Text] [Related]
10. Adverse bone health and abnormal bone turnover among perinatally HIV-infected Asian adolescents with virological suppression.
Sudjaritruk T; Bunupuradah T; Aurpibul L; Kosalaraksa P; Kurniati N; Prasitsuebsai W; Sophonphan J; Sohn AH; Ananworanich J; Puthanakit T;
HIV Med; 2017 Apr; 18(4):235-244. PubMed ID: 27477214
[TBL] [Abstract][Full Text] [Related]
11. Early loss of bone mineral density is correlated with a gain of fat mass in patients starting a protease inhibitor containing regimen: the prospective Lipotrip study.
Bonnet E; Ruidavets JB; Genoux A; Mabile L; Busato F; Obadia M; Prévoteau F; Marchou B; Massip P; Marion-Latard F; Delpierre C; Bernard J; Perret B
BMC Infect Dis; 2013 Jun; 13():293. PubMed ID: 23809140
[TBL] [Abstract][Full Text] [Related]
12. Immediate Initiation of Antiretroviral Therapy for HIV Infection Accelerates Bone Loss Relative to Deferring Therapy: Findings from the START Bone Mineral Density Substudy, a Randomized Trial.
Hoy JF; Grund B; Roediger M; Schwartz AV; Shepherd J; Avihingsanon A; Badal-Faesen S; de Wit S; Jacoby S; La Rosa A; Pujari S; Schechter M; White D; Engen NW; Ensrud K; Aagaard PD; Carr A;
J Bone Miner Res; 2017 Sep; 32(9):1945-1955. PubMed ID: 28650589
[TBL] [Abstract][Full Text] [Related]
13. Lower peak bone mass and abnormal trabecular and cortical microarchitecture in young men infected with HIV early in life.
Yin MT; Lund E; Shah J; Zhang CA; Foca M; Neu N; Nishiyama KK; Zhou B; Guo XE; Nelson J; Bell DL; Shane E; Arpadi SM
AIDS; 2014 Jan; 28(3):345-53. PubMed ID: 24072196
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and risk factors for low bone mineral density in antiretroviral therapy-naive HIV-infected young men.
Paccou J; Viget N; Drumez E; Cortet B; Robineau O
Med Mal Infect; 2018 Oct; 48(7):442-448. PubMed ID: 29699830
[TBL] [Abstract][Full Text] [Related]
15. Obesity and dyslipidemia in behaviorally HIV-infected young women: Adolescent Trials Network study 021.
Mulligan K; Harris DR; Monte D; Stoszek S; Emmanuel P; Hardin DS; Kapogiannis BG; Worrell C; Meyer WA; Sleasman J; Wilson CM; Aldrovandi GM;
Clin Infect Dis; 2010 Jan; 50(1):106-14. PubMed ID: 19947855
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with low bone mineral density in a Brazilian cohort of vertically HIV-infected adolescents.
Schtscherbyna A; Pinheiro MF; Mendonça LM; Gouveia C; Luiz RR; Machado ES; Farias ML
Int J Infect Dis; 2012 Dec; 16(12):e872-8. PubMed ID: 23031418
[TBL] [Abstract][Full Text] [Related]
17. The IMpact of Vertical HIV infection on child and Adolescent SKeletal development in Harare, Zimbabwe (IMVASK Study): a protocol for a prospective cohort study.
Rukuni R; Gregson C; Kahari C; Kowo F; McHugh G; Munyati S; Mujuru H; Ward K; Filteau S; Rehman AM; Ferrand R
BMJ Open; 2020 Feb; 10(2):e031792. PubMed ID: 32041852
[TBL] [Abstract][Full Text] [Related]
18. Bone mass, body composition and vitamin D status of ARV-naïve, urban, black South African women with HIV infection, stratified by CD₄ count.
Hamill MM; Ward KA; Pettifor JM; Norris SA; Prentice A
Osteoporos Int; 2013 Nov; 24(11):2855-61. PubMed ID: 23719859
[TBL] [Abstract][Full Text] [Related]
19. Bone measures in HIV-1 infected children and adolescents: disparity between quantitative computed tomography and dual-energy X-ray absorptiometry measurements.
Pitukcheewanont P; Safani D; Church J; Gilsanz V
Osteoporos Int; 2005 Nov; 16(11):1393-6. PubMed ID: 15702261
[TBL] [Abstract][Full Text] [Related]
20. Different impact of NNRTI and PI-including HAART on bone mineral density loss in HIV-infected patients.
Madeddu G; Spanu A; Solinas P; Babudieri S; Calia GM; Lovigu C; Mannazzu M; Nuvoli S; Piras B; Bagella P; Mura MS; Madeddu G
Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4576-89. PubMed ID: 26698255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
